(CCJ) Cameco - Ratings and Ratios

Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA13321L1085

Uranium, Fuel, Conversion, Reactor, Services

CCJ EPS (Earnings per Share)

EPS (Earnings per Share) of CCJ over the last years for every Quarter: "2020-09": -0.2, "2020-12": 0.12, "2021-03": -0.07, "2021-06": -0.1, "2021-09": -0.14, "2021-12": 0.06, "2022-03": 0.04, "2022-06": 0.18, "2022-09": 0.03, "2022-12": 0.09, "2023-03": 0.27, "2023-06": -0.01, "2023-09": 0.32, "2023-12": 0.21, "2024-03": 0.13, "2024-06": 0.14, "2024-09": -0.01, "2024-12": 0.36, "2025-03": 0.16, "2025-06": 0.71, "2025-09": 0.07,

CCJ Revenue

Revenue of CCJ over the last years for every Quarter: 2020-09: 378.87, 2020-12: 550.356, 2021-03: 290.016, 2021-06: 359.205, 2021-09: 361.216, 2021-12: 464.547, 2022-03: 398.038, 2022-06: 557.577, 2022-09: 388.659, 2022-12: 523.729, 2023-03: 686.975, 2023-06: 481.987, 2023-09: 575.079, 2023-12: 843.717, 2024-03: 633.545, 2024-06: 598.458, 2024-09: 720.596, 2024-12: 1183.173, 2025-03: 789.432, 2025-06: 877.016, 2025-09: 614.555,
Risk via 10d forecast
Volatility 50.6%
Value at Risk 5%th 77.4%
Relative Tail Risk -7.07%
Reward TTM
Sharpe Ratio 1.07
Alpha 40.38
Character TTM
Hurst Exponent 0.292
Beta 1.181
Beta Downside 1.062
Drawdowns 3y
Max DD 40.01%
Mean DD 9.46%
Median DD 6.45%

Description: CCJ Cameco September 29, 2025

Cameco Corp (NYSE:CCJ) is a vertically integrated uranium producer that generates revenue across three business lines: (1) Uranium – exploration, mining, milling, and the sale of uranium concentrate; (2) Fuel Services – conversion, enrichment, and fabrication of nuclear fuel; and (3) Westinghouse – design, construction, and aftermarket support for commercial nuclear reactors.

The company’s customer base spans nuclear utilities in the Americas, Europe, and Asia, positioning it as a primary supplier in a market where long-term contracts dominate pricing and demand is driven by the global push for low-carbon electricity generation.

Key operational metrics from the most recent fiscal year include production of roughly 12.5 million pounds of U₃O₈, cash flow from operations of about $2.1 billion, and a net debt-to-EBITDA ratio of 0.9×, indicating a relatively strong balance sheet for a capital-intensive commodity business.

Sector-wide, the uranium market is currently influenced by three macro drivers: (i) the tightening of supply as legacy mines close, (ii) government policies that earmark nuclear power as a cornerstone of net-zero strategies, and (iii) price volatility stemming from geopolitical tensions that affect both supply chains and the cost of alternative energy sources.

For a deeper dive into Cameco’s valuation metrics and scenario analysis, the ValueRay platform offers a transparent, data-driven framework worth exploring.

CCJ Stock Overview

Market Cap in USD 37,436m
Sub-Industry Coal & Consumable Fuels
IPO / Inception 1996-03-14
Return 12m vs S&P 500 39.5%
Analyst Rating 4.53 of 5

CCJ Dividends

Dividend Yield 0.13%
Yield on Cost 5y 1.21%
Yield CAGR 5y 16.92%
Payout Consistency 94.2%
Payout Ratio 21.8%

CCJ Growth Ratios

CAGR 3y 53.63%
CAGR/Max DD Calmar Ratio 1.34
CAGR/Mean DD Pain Ratio 5.67
Current Volume 4891.6k
Average Volume 4891.6k

Piotroski VR‑10 (Strict, 0-10) 8.0

Net Income (526.0m TTM) > 0 and > 6% of Revenue (6% = 207.9m TTM)
FCFTA 0.10 (>2.0%) and ΔFCFTA 6.56pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 36.28% (prev 35.41%; Δ 0.87pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.13 (>3.0%) and CFO 1.26b > Net Income 526.0m (YES >=105%, WARN >=100%)
Net Debt (228.5m) to EBITDA (1.07b) ratio: 0.21 <= 3.0 (WARN <= 3.5)
Current Ratio 2.99 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (435.4m) change vs 12m ago -0.02% (target <= -2.0% for YES)
Gross Margin 29.05% (prev 23.81%; Δ 5.24pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 36.41% (prev 30.11%; Δ 6.31pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 9.32 (EBITDA TTM 1.07b / Interest Expense TTM 79.9m) >= 6 (WARN >= 3)

Altman Z'' 4.87

(A) 0.13 = (Total Current Assets 1.89b - Total Current Liabilities 631.4m) / Total Assets 9.74b
(B) 0.36 = Retained Earnings (Balance) 3.49b / Total Assets 9.74b
(C) 0.08 = EBIT TTM 744.0m / Avg Total Assets 9.51b
(D) 2.22 = Book Value of Equity 6.57b / Total Liabilities 2.96b
Total Rating: 4.87 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 70.35

1. Piotroski 8.0pt = 3.0
2. FCF Yield 1.84% = 0.92
3. FCF Margin 28.07% = 7.02
4. Debt/Equity 0.15 = 2.49
5. Debt/Ebitda 0.21 = 2.46
6. ROIC - WACC (= -1.24)% = -1.55
7. RoE 7.98% = 0.66
8. Rev. Trend 52.88% = 3.97
9. EPS Trend 27.48% = 1.37

What is the price of CCJ shares?

As of November 15, 2025, the stock is trading at USD 84.76 with a total of 4,891,600 shares traded.
Over the past week, the price has changed by -8.13%, over one month by -9.05%, over three months by +12.19% and over the past year by +59.90%.

Is Cameco a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Cameco (NYSE:CCJ) is currently (November 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 70.35 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CCJ is around 112.14 USD . This means that CCJ is currently undervalued and has a potential upside of +32.3% (Margin of Safety).

Is CCJ a buy, sell or hold?

Cameco has received a consensus analysts rating of 4.53. Therefore, it is recommended to buy CCJ.
  • Strong Buy: 10
  • Buy: 9
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the CCJ price?

Issuer Target Up/Down from current
Wallstreet Target Price 115.1 35.8%
Analysts Target Price 115.1 35.8%
ValueRay Target Price 126.9 49.7%

CCJ Fundamental Data Overview November 15, 2025

Market Cap CAD = 52.49b (37.44b USD * 1.402 USD.CAD)
P/E Trailing = 99.9767
P/E Forward = 65.3595
P/S = 10.8067
P/B = 8.338
P/EG = 3.33
Beta = 1.311
Revenue TTM = 3.46b CAD
EBIT TTM = 744.0m CAD
EBITDA TTM = 1.07b CAD
Long Term Debt = 996.2m CAD (from longTermDebt, last quarter)
Short Term Debt = 289.2m CAD (from shortTermDebt, last fiscal year)
Debt = 1.01b CAD (from shortLongTermDebtTotal, last quarter)
Net Debt = 228.5m CAD (from netDebt column, last quarter)
Enterprise Value = 52.71b CAD (52.49b + Debt 1.01b - CCE 778.7m)
Interest Coverage Ratio = 9.32 (Ebit TTM 744.0m / Interest Expense TTM 79.9m)
FCF Yield = 1.84% (FCF TTM 972.5m / Enterprise Value 52.71b)
FCF Margin = 28.07% (FCF TTM 972.5m / Revenue TTM 3.46b)
Net Margin = 15.18% (Net Income TTM 526.0m / Revenue TTM 3.46b)
Gross Margin = 29.05% ((Revenue TTM 3.46b - Cost of Revenue TTM 2.46b) / Revenue TTM)
Gross Margin QoQ = 37.32% (prev 29.31%)
Tobins Q-Ratio = 5.41 (Enterprise Value 52.71b / Total Assets 9.74b)
Interest Expense / Debt = 0.60% (Interest Expense 6.05m / Debt 1.01b)
Taxrate = 101.0% (out of range, set to none) (15.9m / 15.7m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 2.99 (Total Current Assets 1.89b / Total Current Liabilities 631.4m)
Debt / Equity = 0.15 (Debt 1.01b / totalStockholderEquity, last quarter 6.78b)
Debt / EBITDA = 0.21 (Net Debt 228.5m / EBITDA 1.07b)
Debt / FCF = 0.23 (Net Debt 228.5m / FCF TTM 972.5m)
Total Stockholder Equity = 6.59b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.40% (Net Income 526.0m / Total Assets 9.74b)
RoE = 7.98% (Net Income TTM 526.0m / Total Stockholder Equity 6.59b)
RoCE = 9.80% (EBIT 744.0m / Capital Employed (Equity 6.59b + L.T.Debt 996.2m))
RoIC = 8.93% (EBIT 744.0m / (Assets 9.74b - Curr.Liab 631.4m - Cash 778.7m))
WACC = 10.17% (E(52.49b)/V(53.49b) * Re(10.37%) + (debt cost/tax rate unavailable))
Discount Rate = 10.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.14%
[DCF Debug] Terminal Value 74.25% ; FCFE base≈710.8m ; Y1≈876.8m ; Y5≈1.50b
Fair Price DCF = 39.48 (DCF Value 17.19b / Shares Outstanding 435.4m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 27.48 | EPS CAGR: -8.73% | SUE: -0.93 | # QB: 0
Revenue Correlation: 52.88 | Revenue CAGR: 5.99% | SUE: -0.58 | # QB: 0

Additional Sources for CCJ Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle